IGC Pharma entered into a Stock Purchase Agreement to issue shares to a Purchaser for $0.27 per share. The transaction is scheduled to close on June 30, 2026, and will be settled through the cancellation of existing debt.
IGC Pharma entered into a Stock Purchase Agreement to issue shares to a Purchaser for $0.27 per share. The transaction is scheduled to close on June 30, 2026, and will be settled through the cancellation of existing debt.